Lessons from the U.K., New Zealand and Australia indicate that government-run pharmacare limits access to new drugs, discourages innovation

canadafreepress.com | 12/13/2018 | Fraser Institute
Click For Photo: https://canadafreepress.com/images/uploads/fraser121318.jpg

VANCOUVER—As Canadian policymakers grapple with a potential national pharmacare program, we should learn from the United Kingdom, Australia and New Zealand where publicly-funded pharmacare schemes have resulted in reduced access to new drugs for patients, drug shortages, higher taxes and less pharmaceutical innovation, finds a new study released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.

“Government-run pharmacare programs in countries such as the U.K., Australia and New Zealand have produced unintended consequences for patients, so Canadians should be aware of the risks as...
(Excerpt) Read more at: canadafreepress.com
Wake Up To Breaking News!
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!